Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. A Metabolic Syndrome in Active Subjects in Spain (MESYAS) Registry substudy.

Cardiology Department, Clinica Universitaria de Navarra, Pamplona, Spain.
American Journal of Hypertension (Impact Factor: 3.4). 03/2006; 19(2):189-96; discussion 197-8. DOI: 10.1016/j.amjhyper.2005.08.018
Source: PubMed

ABSTRACT The aim of this study was to assess the prevalence of metabolic syndrome (MS) and other surrogate markers of insulin resistance, and whether these markers are better for defining the prehypertensive state than is renal dysfunction.
Data from 19,041 healthy active workers, mean age 42.2 (10.7) years, from three health insurance companies, were prospectively collected. Presence of MS, assessed according to the modified criteria of the National Cholesterol Education Program Third Adult Treatment Panel, and the ratio of triglycerides to high-density lipoprotein were considered as surrogate markers of insulin resistance. Renal function was assessed by the Modification of Diet in Renal Disease Study equation. Blood pressure was classified as normotension (NT), prehypertension (PHT), or hypertension (HT) according to the guidelines of the seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
The global presence of MS was 11.8% The higher prevalence was found in subjects with hypertension (30%), followed by those with PHT (9.6%). The prevalence in normotensive subjects was very low (0.9%). The presence of MS and hypertension increased in parallel with age. Metabolic syndrome (odds ratio [OR] 4.3), obesity (OR 2.2), overweight (OR 1.7), impaired fasting glucose (OR 1.3), and elevated triglycerides to HDL ratio (OR 1.2), but no degree of renal dysfunction, were independent risk factors for the progression from NT to PHT.
Prehypertension is associated with markers of insulin resistance, assessed by the presence of MS and other surrogate markers, and not with an initial renal dysfunction. In this study, MS was found to be present in almost one third of hypertensive but asymptomatic and otherwise healthy workers.

1 Bookmark
  • [Show abstract] [Hide abstract]
    ABSTRACT: Studies of the association of prehypertension with the incidence of end-stage renal disease (ESRD) after adjusting for other cardiovascular risk factors have shown controversial results. Systematic review and meta-analysis of prospective cohort studies. Adults with prehypertension. Studies evaluating the association of prehypertension with the incidence of ESRD identified by searches in PubMed, EMBASE, and Cochrane Library databases and conference proceedings, without language restriction. Prehypertension. The relative risks (RRs) of ESRD were calculated and reported with 95% CIs. Subgroup analyses were conducted according to blood pressure (BP), age, sex, ethnicity, and study characteristics. Data from 1,003,793 participants were derived from 6 prospective cohort studies. Compared with optimal BP, prehypertension significantly increased the risk of ESRD (RR, 1.59; 95% CI, 1.39-1.91). In subgroup analyses, prehypertension significantly predicted higher ESRD risk across age, sex, ethnicity, and study characteristics. Even low-range (BP, 120-129/80-84mm Hg) prehypertension increased the risk of ESRD compared with optimal BP (RR, 1.44; 95% CI, 1.19-1.74), and the risk increased further with high-range (BP, 130-139/85-89mm Hg) prehypertension (RR, 2.02; 95% CI, 1.70-2.40). The RR was significantly higher in the high-range compared with the low-range prehypertensive population (P=0.01). No access to individual patient-level data. Prehypertension is associated with incident ESRD. The increased risk is driven largely by high-range prehypertension.
    American Journal of Kidney Diseases 09/2013; · 5.76 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Prevention is the most effective and efficient way of tackling cardiovascular disease and, similarly, cardiac rehabilitation programs are the most effective and efficient means of secondary prevention. The main objective of the metabolic syndrome working group is to increase understanding of cardiovascular risk in Spain by studying the occurrence of various risk factors, and the connections and associations between them, in economically active individuals. The group's first study and, subsequently, the MESYAS (Metabolic Syndrome in Active Subjects) study have led to significant and informative new findings, and continue to be produce data that can be used to improve disease prevention in everyday clinical practice. Furthermore, cardiac rehabilitation and secondary prevention programs for cardiovascular disease provide the most effective means of decreasing morbidity and mortality. However, it is worrying to observe that, in cardiological practice, there are significant gaps in compliance with scientific society recommendations on secondary prevention. On request, the coordinator of the cardiac rehabilitation working group has provided a report on the latest data and findings from across the full spectrum of activity in this vital area of disease prevention.
    Revista Espa de Cardiologia 01/2010; 63:40–48. · 3.34 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The Preventive Cardiology and Rehabilitation Section of the Spanish Society of Cardiology provides the principal national reference point for scientific knowledge about cardiovascular risk factors in the Spanish population, about the incidence and prevalence of cardiovascular disease in Spain, and about disease prevention and the use of cardiac rehabilitation to improve the quality of life and prolong the survival of individuals already affected by the disease. By necessity, research into cardiovascular prevention involves sponsoring the implementation of studies into cardiovascular risk factors and disease occurrence. The MESYAS study is a good example. It is the fruit of the combined efforts of members of the metabolic syndrome working group belonging to our Section of the Spanish Society of Cardiology and its aim was to answer a number of unresolved questions that had arisen about the incidence, prevalence and consequences of cardiovascular disease in the Spanish population. Today, after this cohort has been followed up for more than 5 years, the first analysis of the cardiovascular events that occurred in the cohort and their relationship with individual risk factors observed many years previously has become available. Here, the metabolic syndrome working group reports some interesting findings. With the aim of communicating up-to-date information that has undergone expert review, the coordinator of the cardiac rehabilitation working group has the responsibility of summarizing, evaluating and updating the scientific data available on the important subject of the secondary prevention of cardiovascular disease.
    Revista Espa de Cardiologia 01/2011; 64:66–72. · 3.34 Impact Factor

Full-text (2 Sources)

Available from
May 19, 2014